Ethyl bromoacetate → HCID 19357123, compound
Reaction equation
[C:1]([C:4]1[CH:5]=[C:6]([NH:13][C:14]([N:16]2[CH2:21][CH2:20][N:19]([C:22]3[CH:27]=[C:26]([O:28][CH3:29])[CH:25]=[C:24]([O:30][CH3:31])[CH:23]=3)[CH2:18][CH2:17]2)=[O:15])[C:7]([O:11][CH3:12])=[N:8][C:9]=1[CH3:10])(=[O:3])[CH3:2].[H-].[Na+].[CH2:34]([O:36][C:37](=[O:40])[CH2:38]Br)[CH3:35]>>[CH3:29][O:28][C:26]1[CH:27]=[C:22]([N:19]2[CH2:20][CH2:21][N:16]([C:14]([N:13]([C:6]3[C:7]([O:11][CH3:12])=[N:8][C:9]([CH3:10])=[C:4]([C:1](=[O:3])[CH3:2])[CH:5]=3)[CH2:38][C:37]([O:36][CH2:34][CH3:35])=[O:40])=[O:15])[CH2:17][CH2:18]2)[CH:23]=[C:24]([O:30][CH3:31])[CH:25]=1Participants
4
Procedure
1-[(5-Acetyl-2-methoxy-6-methylpyridin-3-yl)aminocarbonyl]-4-(3,5-dimethoxylphenyl)piperazine(200 mg, 0.5 mmol) was dissolved in dimethylfornamide(15 ml) and thereto sodium hydride(18.5 mg, 0.5 mmol) was added, then followed by stirring at room temperature for 15 min, and ethylbromoacetate(83.5 mg, 0.5 mmol) was added. The resulting mixture was stirred at room temperature for 3 hrs, concentrated under the reduced pressure to remove the used solvent, and purified by column chromatography(ethylacetate:hexane=1:2) to obtain the titled compound.
Workup
- stirringThe resulting mixture was stirred at room temperature for 3 hrs
- concentrationconcentrated under the reduced pressure
- customto remove the used solvent
- custompurified by column chromatography(ethylacetate:hexane=1:2)
Sources & evidence
- ORD record
- ord-a3e8070cbc69429b904327e300ea44b7
- Source dataset
- uspto-grants-2000_02
- Patent number
- US06028195
Reaction notes
Loading…